How many studies have been conducted on Glp-1 Agonists?

BiohacksAI has indexed 299 PubMed studies on Glp-1 Agonists, including 1 randomized controlled trials (RCTs). 37% of studies involve human subjects.

What are the main research areas for Glp-1 Agonists?

The primary research domains for Glp-1 Agonists are 🔥 Metabolic, 🦠 Gut & Microbiome, 🧬 Hormones. This is based on analysis of 299 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Glp-1 Agonists

Glucagon-Like Peptide-1 Receptor Agonists [Pharmacological Action]

299+ PubMed studies analyzed · 1 RCTs · Evidence Score: 44.4

Research Domains

Glp-1 Agonists has been studied across 16 research domains including 🔥 Metabolic, 🦠 Gut & Microbiome, 🧬 Hormones, ❤️ Cardiovascular, 🫁 Liver & Detox. The primary research focus is 🔥 Metabolic with 73% of studies addressing this area.

Loading evidence profile...

This evidence profile for Glp-1 Agonists is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.